BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Karaman K, Bostanci EB, Ercan M, Kurt M, Teke Z, Reyhan E, Akoglu M. Topical Ankaferd Application to Presacral Bleeding due to Total Mesorectal Excision in Rectal Carcinoma. Journal of Investigative Surgery 2010;23:175-175. [DOI: 10.3109/08941930903564134] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Simsek C, Selek S, Koca M, Haznedaroglu IC. Proteomic and transcriptomic analyses to explain the pleiotropic effects of Ankaferd blood stopper. SAGE Open Med 2017;5:2050312117722569. [PMID: 28839937 DOI: 10.1177/2050312117722569] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
2 Casal Núñez JE, Vigorita V, Ruano Poblador A, Gay Fernández AM, Toscano Novella M&, Cáceres Alvarado N, Pérez Dominguez L. Presacral venous bleeding during mobilization in rectal cancer. World J Gastroenterol 2017; 23(9): 1712-1719 [PMID: 28321171 DOI: 10.3748/wjg.v23.i9.1712] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
3 Sharma S. What's New in Critical Illness and Injury Science? Coagulants for local application in the surgical armamentarium! Int J Crit Illn Inj Sci 2016;6:161-2. [PMID: 28149817 DOI: 10.4103/2229-5151.195388] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
4 Cuicchi D, Lecce F, Dalla Via B, De Raffele E, Mirarchi M, Cola B. Mortality and Morbidity. Updates in Surgery 2016. [DOI: 10.1007/978-88-470-5767-8_8] [Reference Citation Analysis]
5 Karaman K, Bostanci EB, Celep B, Dincer N, Kurt M, Teke Z, Akoglu M, Bilgili H, Ulusan S, Haznedaroglu IC. In Vivo Healing Effects of Ankaferd Blood Stopper on the Residual Pancreatic Tissue in a Swine Model of Distal Pancreatectomy. Indian J Surg 2015;77:176-81. [PMID: 26246697 DOI: 10.1007/s12262-013-0828-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
6 Batgi H, Akbal E, Koçak E, Akyürek Ö, Köklü S, Dönmez M, Güneş F. Treatment of hemorrhagic gastritis by Ankaferd blood stopper versus Omeprazole: experimental randomized rat models. Wien Klin Wochenschr 2016;128:559-65. [PMID: 25860852 DOI: 10.1007/s00508-015-0762-2] [Reference Citation Analysis]
7 Lou Z, Zhang W, Meng RG, Fu CG. Massive presacral bleeding during rectal surgery: From anatomy to clinical practice. World J Gastroenterol 2013; 19(25): 4039-4044 [PMID: 23840150 DOI: 10.3748/wjg.v19.i25.4039] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
8 Akalin C, Kuru S, Barlas AM, Kismet K, Kaptanoglu B, Demir A, Astarci HM, Ustun H, Ertas E. Beneficial effects of Ankaferd Blood Stopper on dermal wound healing: an experimental study. Int Wound J 2014;11:64-8. [PMID: 22943603 DOI: 10.1111/j.1742-481X.2012.01063.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
9 Leblebisatan G, Bay A, Karakus SC, Kekilli M, Haznedaroglu IC. Topical Ankaferd hemostat application for the management of oral cavity bleedings in children with hemorrhagic diathesis. Blood Coagulation & Fibrinolysis 2012;23:494-7. [DOI: 10.1097/mbc.0b013e32834fa837] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
10 Haznedaroglu BZ, Beyazit Y, Walker SL, Haznedaroglu IC. Pleiotropic cellular, hemostatic, and biological actions of Ankaferd hemostat. Crit Rev Oncol Hematol 2012;83:21-34. [PMID: 22079213 DOI: 10.1016/j.critrevonc.2011.10.006] [Cited by in Crossref: 35] [Cited by in F6Publishing: 47] [Article Influence: 2.9] [Reference Citation Analysis]
11 Guler M, Maralcan G, Kul S, Baskonus I, Yilmaz M. The Efficacy of Ankaferd Blood Stopper for the Management of Bleeding Following Total Thyroidectomy. Journal of Investigative Surgery 2011;24:205-10. [DOI: 10.3109/08941939.2011.586092] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
12 Karabiyik A, Güleç S, Yilmaz E, Haznedaroglu I, Akar N. Reversible Protease-Activated Receptor I Downregulation Mediated by Ankaferd Blood Stopper Inducible With Lipopolysaccharides Inside the Human Umbilical Vein Endothelial Cells. Clin Appl Thromb Hemost. 2011;Epub ahead of print. [PMID: 21406410 DOI: 10.1177/1076029610394437] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]